Letter
NICE behaviour
QALYs in the community
Cite this as:
BMJ
2007;335:527.3
- Andrew N Bamji, consultant rheumatologist
- Queen Mary's Hospital, Sidcup, Kent DA14 6LT
- bamji{at}btinternet.com
One of the major concerns of rheumatologists (who have been involved with submissions to the National Institute for Health and Clinical Excellence (NICE) for a series of expensive drugs for the treatment of rheumatoid arthritis and other inflammatory joint diseases) is “what is contained in a QALY assessment.”1 The answer, …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Ethical considerations
Published 14 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 14 February 2012
Re: Raised inflammatory markers
Published 14 February 2012
Re: Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Published 14 February 2012
Smokefree cars in Wales: Laws are better
Published 14 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012